| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amarin Corp Plc\uk (AMRN) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. AMRN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 80.7K | $1.29M | - | |
| COO | 9.7K | $155.7K | - | |
| CFO | 6.4K | $103.2K | - | |
| VP | 3.7K | $59.1K | - | |
| VP | 2.2K | $35.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 29, 2019 | Stack David M67 | Director | Sale+OE | 33,799 | $18.45 | $623,534.09 | -100% | |
| May 17, 2019 | Stack David M67 | Director | Sale+OE | 13,174 | $18.00 | $237,138.59 | -100% | |
| Apr 30, 2019 | Kennedy Joseph T | General Counsel | Sale+OE | 27,230 | $18.69 | $508,838.84 | -46.6% | |
| Apr 30, 2019 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 9,541 | $18.67 | $178,106.62 | -2.6% | |
| Apr 1, 2019 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 9,542 | $20.06 | $191,391.99 | -1.3% | |
| Apr 1, 2019 | Kennedy Joseph T | General Counsel | Sale+OE | 54,172 | $20.05 | $1,086,121.58 | -46.0% | |
| Mar 4, 2019 | Thero John F | President And CEO | Sell | 250,000 | $21.31 | $5,327,233.76 | -5.6% | |
| Mar 4, 2019 | Ekman Lars73 | Director | Sale+OE | 135,377 | $21.31 | $2,884,904.79 | -78.7% | |
| Mar 1, 2019 | Kalb Michael Wayne | SVP And CFO | Sale+OE | 100,000 | $22.09 | $2,209,098.34 | -36.2% | |
| Mar 1, 2019 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 55,543 | $21.85 | $1,213,524.05 | -3.6% |